Exosomes in Alzheimer's Disease: From Being Pathological Players to Potential Diagnostics and Therapeutics

被引:54
作者
Soliman, Hagar M. [1 ]
Ghonaim, Ghada A. [1 ]
Gharib, Shaza M. [1 ]
Chopra, Hitesh [2 ]
Farag, Aya K. [1 ]
Hassanin, Mohamed H. [1 ]
Nagah, Abdalrazeq [1 ]
Emad-Eldin, Mahmoud [3 ]
Hashem, Nevertary E. [1 ]
Yahya, Galal [4 ]
Emam, Sherif E. [1 ]
Hassan, Abdalla E. A. [5 ]
Attia, Mohamed S. [1 ]
机构
[1] Zagazig Univ, Fac Pharm, Dept Pharmaceut, Zagazig 44519, Egypt
[2] Chitkara Univ, Chitkara Coll Pharm, Chandigarh 140401, Punjab, India
[3] Zagazig Univ, Fac Pharm, Dept Clin, Zagazig 44519, Egypt
[4] Zagazig Univ, Fac Pharm, Dept Microbiol & Immunol, Zagazig 44519, Egypt
[5] Appl Nucle Acids Res Ctr & Chem, Fac Sci, Zagazig 44519, Egypt
关键词
exosomes; neurodegenerative disorders; drug delivery; diagnosis; treatment; cargo; microfluidics; BLOOD-BRAIN-BARRIER; MESENCHYMAL STROMAL CELLS; AMYLOID PRECURSOR PROTEIN; NF-KAPPA-B; CEREBROSPINAL-FLUID; EXTRACELLULAR VESICLES; PROGNOSTIC BIOMARKER; COGNITIVE DECLINE; LUNG-CANCER; TAU-PROTEIN;
D O I
10.3390/ijms221910794
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Exosomes (EXOs) were given attention as an extracellular vesicle (EV) with a pivotal pathophysiological role in the development of certain neurodegenerative disorders (NDD), such as Parkinson's and Alzheimer's disease (AD). EXOs have shown the potential to carry pathological and therapeutic cargo; thus, researchers have harnessed EXOs in drug delivery applications. EXOs have shown low immunogenicity as natural drug delivery vehicles, thus ensuring efficient drug delivery without causing significant adverse reactions. Recently, EXOs provided potential drug delivery opportunities in AD and promising future clinical applications with the diagnosis of NDD and were studied for their usefulness in disease detection and prediction prior to the emergence of symptoms. In the future, the microfluidics technique will play an essential role in isolating and detecting EXOs to diagnose AD before the development of advanced symptoms. This review is not reiterative literature but will discuss why EXOs have strong potential in treating AD and how they can be used as a tool to predict and diagnose this disorder.
引用
收藏
页数:20
相关论文
共 150 条
[1]   Astrocyte-endothelial interactions and blood-brain barrier permeability [J].
Abbott, NJ .
JOURNAL OF ANATOMY, 2002, 200 (06) :629-638
[2]   Plasma neuronal exosomal levels of Alzheimer's disease biomarkers in normal aging [J].
Abner, Erin L. ;
Jicha, Gregory A. ;
Shaw, Leslie M. ;
Trojanowski, John Q. ;
Goetzl, Edward J. .
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2016, 3 (05) :399-403
[3]   Therapeutic Potential of Dental Pulp Stem Cell Secretome for Alzheimer's Disease Treatment: An In Vitro Study [J].
Ahmed, Nermeen El-Moataz Bellah ;
Murakami, Masashi ;
Hirose, Yujiro ;
Nakashima, Misako .
STEM CELLS INTERNATIONAL, 2016, 2016
[4]   Naturally Occurring Exosome Vesicles as Potential Delivery Vehicle for Bioactive Compounds [J].
Akuma, Precious ;
Okagu, Ogadimma D. ;
Udenigwe, Chibuike C. .
FRONTIERS IN SUSTAINABLE FOOD SYSTEMS, 2019, 3
[5]   Hyperphosphorylation induces self-assembly of τ into tangles of paired helical filaments/straight filaments [J].
Alonso, AD ;
Zaidi, T ;
Novak, M ;
Grundke-Iqbal, I ;
Iqbal, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (12) :6923-6928
[6]   Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes [J].
Alvarez-Erviti, Lydia ;
Seow, Yiqi ;
Yin, HaiFang ;
Betts, Corinne ;
Lakhal, Samira ;
Wood, Matthew J. A. .
NATURE BIOTECHNOLOGY, 2011, 29 (04) :341-U179
[7]   Exosomes neutralize synaptic-plasticity-disrupting activity of Aβ assemblies in vivo [J].
An, Kyongman ;
Klyubin, Igor ;
Kim, Youngkyu ;
Jung, Jung Hoon ;
Mably, Alexandra J. ;
O'Dowd, Sean T. ;
Lynch, Timothy ;
Kanmert, Daniel ;
Lemere, Cynthia A. ;
Finan, Gina M. ;
Park, Joon Won ;
Kim, Tae-Wan ;
Walsh, Dominic M. ;
Rowan, Michael J. ;
Kim, Joung-Hun .
MOLECULAR BRAIN, 2013, 6
[8]   Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice [J].
Andreasen, N ;
Minthon, L ;
Davidsson, P ;
Vanmechelen, E ;
Vanderstichele, H ;
Winblad, B ;
Blennow, K .
ARCHIVES OF NEUROLOGY, 2001, 58 (03) :373-379
[9]   Extracellular Vesicles and the Promise of Continuous Liquid Biopsies [J].
Armstrong, Don ;
Wildman, Derek E. .
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2018, 52 (01) :1-8
[10]   Depletion of microglia and inhibition of exosome synthesis halt tau propagation [J].
Asai, Hirohide ;
Ikezu, Seiko ;
Tsunoda, Satoshi ;
Medalla, Maria ;
Luebke, Jennifer ;
Haydar, Tank ;
Wolozin, Benjamin ;
Butovsky, Oleg ;
Kuegler, Sebastian ;
Ikezu, Tsuneya .
NATURE NEUROSCIENCE, 2015, 18 (11) :1584-1593